Journal News

Discovery could lead to more potent garlic, boosting flavor and bad breath

Max Esterhuizen
By Max Esterhuizen
Aug. 16, 2020

For centuries, people around the world have used garlic as a spice, natural remedy, and pest deterrent – but they didn’t know how powerful or pungent the heads of garlic were until they tasted them.

But what if farmers were able to grow garlic and know exactly how potent it would be? What if buyers could pick their garlic based on its might?

A team of Virginia Tech researchers recently discovered a new step in the metabolic process that produces the enzyme allicin, which leads to garlic’s delectable flavor and aroma, a finding that upends decades of previous scientific belief. Their work could boost the malodorous - yet delicious - characteristics that garlic-lovers the world over savor.

“This information changes the whole story about how garlic could be improved or we could make the compounds responsible of its unique flavor,” said Hannah Valentino, a College of Agriculture and Life Sciences Ph.D. candidate. “This could lead to a new strain of garlic that would produce more flavor.”

The discovery of this pathway opens the door for better control of production and more consistent crops, which would help farmers. Garlic could be sold as strong or weak, depending on consumer preferences.

The research was recently published in the Journal of Biological Chemistry.

When Valentino, an Institute for Critical Technology and Applied Science doctoral fellow, and her team set out to test the generally accepted biological process that creates allicin, they found it just didn’t happen.

That’s when the team of researchers set out to discover what was really happening in garlic.

As they peeled back the layers, they realized there was no fuel to power the previous accepted biological process that creates allicin.

“By using rational design, Hannah found a potential substrate,” said Pablo Sobrado, professor of biochemistry in the College of Agriculture and Life Sciences and a member of the research team. “This is significant because by finding the metabolic pathway and understanding how the enzyme actually works and its structure gives us a blueprint of how allicin is created during biosynthesis.”

Valentino and the team – which included undergraduate students – worked in the Sobrado Lab in the Fralin Life Sciences Institute directly with the substrates that comprise garlic, doing their work solely in vitro.

Valentino-Sobrado-890x593.jpg
Hannah Valentino, left, and Pablo Sobrado, right, are conducting research that is laying the foundation for a future in which buyers can choose garlic based on its strength and flavor profile.

The researchers found that allicin, the component that gives garlic its smell and flavor, was produced by an entirely different biosynthetic process. Allyl-mercaptan reacts with flavin-containing monooxygenase, which then becomes allyl-sulfenic acid.

Importantly, the allicin levels can be tested, allowing farmers to know the strength of their crops without the need for genetic engineering. Greater flavor can simply be predicted, meaning powerful garlic could simply be bred or engineered.

“We have a basic understanding of the biosynthesis of allicin that it is involved in flavor and smell, but we also now understand an enzyme that we can try to modulate, or a modify, to increase or decrease the level of the flavor molecules based on these biological processes,” Sobrado said.   

Because of their work, the future awaits for fields of garlic harsh enough to keep even the most terrifying vampires at bay.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Max Esterhuizen
Max Esterhuizen

Max Esterhuizen is a communications and marketing specialist who has spent his career in higher education and in sports journalism. As the assistant director for communications and marketing for the College of Agriculture and Life Sciences at Virginia Tech, Max tells and shares stories inside the college, AREC, and Virginia Cooperative Extension. He also helps lead the Office of Communications and Marketing in a digital-first strategy that aligns with the college’s advancement priorities and helps promote the research and academics of the college as well as the impact of Virginia Cooperative Extension and Virginia Agricultural Experiment Station. While in the college, Max has served as the editor of the college’s flagship publication, which has won national awards and landed media placements in outlets ranging from NPR’s Science Friday to Rolling Stone.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Omega-3 fats linked to healthy aging and improved heart metabolism
Journal News

Omega-3 fats linked to healthy aging and improved heart metabolism

Aug. 1, 2025

Scientists from the University of Iowa find that a diet high in polyunsaturated fatty acids from fish oil increases cardiac triglyceride uptake and improves insulin sensitivity. Read more about this recent JLR study.

RA patient blood reveals joint innerworkings
Journal News

RA patient blood reveals joint innerworkings

July 25, 2025

Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

Defeating deletions and duplications
News

Defeating deletions and duplications

July 11, 2025

Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader–Willi syndrome.

Using 'nature’s mistakes' as a window into Lafora disease
Feature

Using 'nature’s mistakes' as a window into Lafora disease

July 10, 2025

After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.